Debate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low"
The importance of low-density lipoprotein (LDL) control in the management of patients at high risk of cardiovascular events is unquestionable. The major statin trials have shown that the benefits of LDL lowering extend throughout the range of risk and the range of serum cholesterol, and have indicat...
Uloženo v:
| Vydáno v: | Curr Control Trials Cardiovasc Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2001
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59646/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11806766/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-2-1-008 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|